LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes

Contributed by: Business Wire

Logo

Tags

FDA

Health Technology

Finance

Surgery

Professional Services

Mental Health

General Health

Medical Devices

Hospitals

Clinical Trials

Cardiology

Science

Biotechnology

Health

Research

Senior Notes

More Like This

LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029

LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results

LivaNova to Announce Third-Quarter 2024 Results

LivaNova to Announce First-Quarter 2024 Results

LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results

LivaNova to Announce Second-Quarter 2024 Results

LivaNova to Announce First-Quarter 2025 Results

LivaNova to Present at the Piper Sandler Healthcare Conference